These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15857579)

  • 1. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
    Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
    Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG methylation of transcription factor 4 in gastric carcinoma.
    Joo JK; Kim SH; Kim HG; Kim DY; Ryu SY; Lee KH; Lee JH
    Ann Surg Oncol; 2010 Dec; 17(12):3344-53. PubMed ID: 20585880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island hypermethylation in progression of esophageal and gastric cancer.
    Sato F; Meltzer SJ
    Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and hepatocellular carcinoma.
    Zhu J
    J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
    Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
    Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
    Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis.
    Nardone G; Compare D; De Colibus P; de Nucci G; Rocco A
    Dig Dis; 2007; 25(3):225-9. PubMed ID: 17827945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic analysis of the KLF4 gene in gastric cancer.
    Cho YG; Song JH; Kim CJ; Nam SW; Yoo NJ; Lee JY; Park WS
    APMIS; 2007 Jul; 115(7):802-8. PubMed ID: 17614846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
    Zouridis H; Deng N; Ivanova T; Zhu Y; Wong B; Huang D; Wu YH; Wu Y; Tan IB; Liem N; Gopalakrishnan V; Luo Q; Wu J; Lee M; Yong WP; Goh LK; Teh BT; Rozen S; Tan P
    Sci Transl Med; 2012 Oct; 4(156):156ra140. PubMed ID: 23076357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P; Vindigni C; Roviello F; Renieri A; Giordano A
    J Cell Physiol; 2007 May; 211(2):287-95. PubMed ID: 17238139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis.
    Milne AN; Sitarz R; Carvalho R; Polak MM; Ligtenberg M; Pauwels P; Offerhaus GJ; Weterman MA
    Hum Pathol; 2007 Jun; 38(6):903-13. PubMed ID: 17376510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
    Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.
    Otani K; Li X; Arakawa T; Chan FK; Yu J
    Expert Rev Mol Diagn; 2013 Jun; 13(5):445-55. PubMed ID: 23782252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.